Saka H - Search Results

1

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

Hida T, Nishio M, Nogami N, Ohe Y, Nokihara H, Sakai H, Satouchi M, Nakagawa K, Takenoyama M, Isobe H, Fujita S, Tanaka H, Minato K, Takahashi T, Maemondo M, Takeda K, Saka H, Goto K, Atagi S, Hirashima T, Sumiyoshi N, Tamura T. Hida T, et al. Among authors: saka h. Cancer Sci. 2017 May;108(5):1000-1006. doi: 10.1111/cas.13225. Epub 2017 Apr 26. Cancer Sci. 2017. PMID: 28266091 Free PMC article. Clinical Trial.

2

High dose chemotherapy with autologous bone marrow transplantation for limited small cell lung cancer.

Nomura F, Shimokata K, Saito H, Watanabe A, Saka H, Sakai S, Kodera Y, Saito H. Nomura F, et al. Among authors: saka h. Jpn J Clin Oncol. 1990 Mar;20(1):94-8. Jpn J Clin Oncol. 1990. PMID: 2157084

3

Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer.

Saito H, Shimokata K, Yamamoto M, Saka H, Sakai S, Kawachi H, Saito H. Saito H, et al. Among authors: saka h. Cancer Chemother Pharmacol. 1990;27(3):251-2. doi: 10.1007/BF00685723. Cancer Chemother Pharmacol. 1990. PMID: 2176135 Clinical Trial.

4

Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.

Nomura F, Shimokata K, Saito H, Sakai S, Watanabe A, Saka H. Nomura F, et al. Among authors: saka h. Cancer Chemother Pharmacol. 1987;20(4):324-6. doi: 10.1007/BF00262585. Cancer Chemother Pharmacol. 1987. PMID: 2826032

5

Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.

Watanabe A, Ichiyama S, Shimokata K, Nagura E, Saito H, Saka H, Nomura F, Sakai S, Saito H. Watanabe A, et al. Among authors: saka h. Nagoya J Med Sci. 1993 Mar;55(1-4):41-6. Nagoya J Med Sci. 1993. PMID: 8247105

6

Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancer.

Saito H, Shimokata K, Saka H, Yamamoto M, Ogasawara T, Nomura F, Sakai S, Iwata M, Murate T, Miyachi T, et al. Saito H, et al. Among authors: saka h. Cancer Chemother Pharmacol. 1993;33(2):154-6. doi: 10.1007/BF00685334. Cancer Chemother Pharmacol. 1993. PMID: 8261575 Clinical Trial.

7

Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer.

Saito H, Shimokata K, Yamamoto M, Saka H, Sakai S, Saito H. Saito H, et al. Among authors: saka h. Cancer Chemother Pharmacol. 1993;32(2):134-6. doi: 10.1007/BF00685616. Cancer Chemother Pharmacol. 1993. PMID: 8387399 Clinical Trial.

8

Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.

Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata K. Ando Y, et al. Among authors: saka h. Jpn J Cancer Res. 1996 Feb;87(2):200-5. doi: 10.1111/j.1349-7006.1996.tb03159.x. Jpn J Cancer Res. 1996. PMID: 8609070 Free PMC article. Clinical Trial.

9

Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro.

Mogi H, Hasegawa Y, Watanabe A, Nomura F, Saka H, Shimokata K. Mogi H, et al. Among authors: saka h. Cancer Chemother Pharmacol. 1997;39(3):199-204. doi: 10.1007/s002800050560. Cancer Chemother Pharmacol. 1997. PMID: 8996520

10

Chemotherapy for small-cell lung cancer: more is not better.

Saka H, Shimokata K. Saka H, et al. Cancer Chemother Pharmacol. 1997;40 Suppl:S107-9. doi: 10.1007/s002800051071. Cancer Chemother Pharmacol. 1997. PMID: 9272144 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

657 results

Search Page

Filters